
Monday, September 21, 2020 10:14:35 AM
Trade at your own risk. Do not make any financial decisions based on anything that I write.
Recent BRTX News
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/28/2025 12:57:11 PM
- BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain • GlobeNewswire Inc. • 02/27/2025 02:45:00 PM
- BioRestorative Announces Updated Time for February 27th Webcasted Conference Call to Discuss Clinical Pipeline Update • GlobeNewswire Inc. • 02/27/2025 01:15:00 AM
- BioRestorative to Provide a Positive FDA Update on Clinical Pipeline • GlobeNewswire Inc. • 02/25/2025 01:00:00 PM
- BioRestorative Receives FDA Fast Track Designation for BRTX-100 Chronic Lumbar Disc Disease Program • GlobeNewswire Inc. • 02/20/2025 01:30:00 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 02/19/2025 09:43:29 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 02/19/2025 09:39:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2025 09:33:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2025 09:31:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2025 09:29:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2025 09:26:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2025 09:25:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2025 09:22:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/10/2025 01:32:48 PM
- BRTX-100 Front and Center at ORS 2025 • GlobeNewswire Inc. • 02/10/2025 12:00:00 PM
- BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting ThermoStem® Metabolic Disease Program • GlobeNewswire Inc. • 12/05/2024 11:45:00 AM
- BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data • GlobeNewswire Inc. • 11/13/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 09:15:39 PM
- BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/12/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2024 09:43:22 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/06/2024 09:37:48 PM
VAYK Proposes 100 million Buyback through Private Repurchases • VAYK • Feb 28, 2025 9:00 AM
ConnectM Eliminates an Additional $1.9 Million of Debt • CNTM • Feb 27, 2025 4:01 PM
Consumer Automotive Finance, Inc. Announces Nationwide Teleconference as It Transitions to Fifty 1 Labs, Inc. • CAFI • Feb 27, 2025 9:00 AM
VPR Brands Secures Settlement Agreement With POP Vapor, Reinforcing Commitment to Intellectual Property Protection • VPRB • Feb 27, 2025 8:49 AM
Wytec Begins Sales of Its Multi-Government AI Threat Detection Sensor Technology • WYTC • Feb 27, 2025 7:05 AM
VAYK Issues Clerical Correction to Feb 18 News Regarding Shareholder Premium • VAYK • Feb 26, 2025 10:32 AM